Login to Your Account



Genzyme Still In Buying Mood: $215M For Cancer Diagnostics

By Randall Osborne


Tuesday, March 2, 2004
On the heels of making known its plan to buy ILEX Oncology Inc. for $1 billion, Genzyme Corp. has taken the lead-bidder position to buy the Physician Services unit of Impath Inc., which filed for bankruptcy in September and sold off another unit late last year. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription